Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1141707

Cover Image

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1141707

Specialty Generics Market Research Report by Type, Application, End-use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

PUBLISHED:
PAGES: 243 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Online Access - 1 Year (Single User License)
USD 3949
PDF, Excel & Online Access - 1 Year (Single User License)
USD 4949
PDF, Excel & Online Access - 1 Year (Up to 5 User License)
USD 5949
PDF, Excel & Online Access - 1 Year (Site License)
USD 7949
PDF, Excel & Online Access - 1 Year (Enterprise User License)
USD 9949

Add to Cart

The Global Specialty Generics Market size was estimated at USD 69.98 billion in 2021 and expected to reach USD 77.02 billion in 2022, and is projected to grow at a CAGR 10.31% to reach USD 126.12 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Specialty Generics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Injectables and Oral drugs.

Based on Application, the market was studied across Hepatitis C, Inflammatory conditions, Multiple sclerosis, and Oncology.

Based on End-use, the market was studied across Hospital Pharmacy, Retail Pharmacy, and Specialty Pharmacy.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Specialty Generics market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Specialty Generics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Specialty Generics Market, including Akorn Operating Company LLC, Apotex Inc., Aspen Group, Aurobindo Pharma Limited, Bausch Health Companies Inc., Cipla Limited, Dr. Reddy's Laboratories Ltd., Endo International PLC, Fresenius Kabi AG, Generic Specialties, Inc., Hikma Pharmaceuticals PLC, Lupin Limited, Mallinckrodt Pharmaceuticals, Novartis AG, Pfizer Inc., Stada Arzneimittel AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Limited.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Specialty Generics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Specialty Generics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Specialty Generics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Specialty Generics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Specialty Generics Market?
  • 6. What is the market share of the leading vendors in the Global Specialty Generics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Specialty Generics Market?
Product Code: MRR-205091A88B86

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing adoption of specialty generic medicines for the treatment of complex chronic diseases
      • 5.1.1.2. Rising incidences of chronic diseases
      • 5.1.1.3. Presence of supportive regulatory policies regarding the approval of new products
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with specialty generics
    • 5.1.3. Opportunities
      • 5.1.3.1. Availability of medically advanced companies and proliferating research & development programs
      • 5.1.3.2. High patient population and growing demand for affordable healthcare facilities
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding development and marketing costs
  • 5.2. Cumulative Impact of COVID-19

6. Specialty Generics Market, by Type

  • 6.1. Introduction
  • 6.2. Injectables
  • 6.3. Oral drugs

7. Specialty Generics Market, by Application

  • 7.1. Introduction
  • 7.2. Hepatitis C
  • 7.3. Inflammatory conditions
  • 7.4. Multiple sclerosis
  • 7.5. Oncology

8. Specialty Generics Market, by End-use

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Retail Pharmacy
  • 8.4. Specialty Pharmacy

9. Americas Specialty Generics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Specialty Generics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Specialty Generics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis, By Key Player
  • 12.3. Market Share Analysis, By Key Player
  • 12.4. Competitive Scenario
    • 12.4.1. Merger & Acquisition
    • 12.4.2. Agreement, Collaboration, & Partnership
    • 12.4.3. New Product Launch & Enhancement
    • 12.4.4. Investment & Funding
    • 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Akorn Operating Company LLC
    • 13.1.1. Business Overview
    • 13.1.2. Key Executives
    • 13.1.3. Product & Services
  • 13.2. Apotex Inc.
    • 13.2.1. Business Overview
    • 13.2.2. Key Executives
    • 13.2.3. Product & Services
  • 13.3. Aspen Group
    • 13.3.1. Business Overview
    • 13.3.2. Key Executives
    • 13.3.3. Product & Services
  • 13.4. Aurobindo Pharma Limited
    • 13.4.1. Business Overview
    • 13.4.2. Key Executives
    • 13.4.3. Product & Services
  • 13.5. Bausch Health Companies Inc.
    • 13.5.1. Business Overview
    • 13.5.2. Key Executives
    • 13.5.3. Product & Services
  • 13.6. Cipla Limited
    • 13.6.1. Business Overview
    • 13.6.2. Key Executives
    • 13.6.3. Product & Services
  • 13.7. Dr. Reddy's Laboratories Ltd.
    • 13.7.1. Business Overview
    • 13.7.2. Key Executives
    • 13.7.3. Product & Services
  • 13.8. Endo International PLC
    • 13.8.1. Business Overview
    • 13.8.2. Key Executives
    • 13.8.3. Product & Services
  • 13.9. Fresenius Kabi AG
    • 13.9.1. Business Overview
    • 13.9.2. Key Executives
    • 13.9.3. Product & Services
  • 13.10. Generic Specialties, Inc.
    • 13.10.1. Business Overview
    • 13.10.2. Key Executives
    • 13.10.3. Product & Services
  • 13.11. Hikma Pharmaceuticals PLC
    • 13.11.1. Business Overview
    • 13.11.2. Key Executives
    • 13.11.3. Product & Services
  • 13.12. Lupin Limited
    • 13.12.1. Business Overview
    • 13.12.2. Key Executives
    • 13.12.3. Product & Services
  • 13.13. Mallinckrodt Pharmaceuticals
    • 13.13.1. Business Overview
    • 13.13.2. Key Executives
    • 13.13.3. Product & Services
  • 13.14. Novartis AG
    • 13.14.1. Business Overview
    • 13.14.2. Key Executives
    • 13.14.3. Product & Services
  • 13.15. Pfizer Inc.
    • 13.15.1. Business Overview
    • 13.15.2. Key Executives
    • 13.15.3. Product & Services
  • 13.16. Stada Arzneimittel AG
    • 13.16.1. Business Overview
    • 13.16.2. Key Executives
    • 13.16.3. Product & Services
  • 13.17. Sun Pharmaceutical Industries Ltd.
    • 13.17.1. Business Overview
    • 13.17.2. Key Executives
    • 13.17.3. Product & Services
  • 13.18. Teva Pharmaceutical Industries Ltd.
    • 13.18.1. Business Overview
    • 13.18.2. Key Executives
    • 13.18.3. Product & Services
  • 13.19. Viatris Inc.
    • 13.19.1. Business Overview
    • 13.19.2. Key Executives
    • 13.19.3. Product & Services
  • 13.20. Zydus Lifesciences Limited
    • 13.20.1. Business Overview
    • 13.20.2. Key Executives
    • 13.20.3. Product & Services

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
Product Code: MRR-205091A88B86

LIST OF FIGURES

  • FIGURE 1. GLOBAL SPECIALTY GENERICS MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL SPECIALTY GENERICS MARKET SIZE, 2021 VS 2027
  • FIGURE 3. GLOBAL SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 4. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
  • FIGURE 5. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 6. GLOBAL SPECIALTY GENERICS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
  • FIGURE 7. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 8. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 9. GLOBAL SPECIALTY GENERICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
  • FIGURE 10. GLOBAL SPECIALTY GENERICS MARKET DYNAMICS
  • FIGURE 11. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
  • FIGURE 12. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
  • FIGURE 13. GLOBAL SPECIALTY GENERICS MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2027
  • FIGURE 14. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY INJECTABLES, 2018-2027 (USD MILLION)
  • FIGURE 15. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY ORAL DRUGS, 2018-2027 (USD MILLION)
  • FIGURE 16. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
  • FIGURE 17. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
  • FIGURE 18. GLOBAL SPECIALTY GENERICS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
  • FIGURE 19. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY HEPATITIS C, 2018-2027 (USD MILLION)
  • FIGURE 20. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY INFLAMMATORY CONDITIONS, 2018-2027 (USD MILLION)
  • FIGURE 21. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2027 (USD MILLION)
  • FIGURE 22. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD MILLION)
  • FIGURE 23. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2021 VS 2027 (%)
  • FIGURE 24. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2021 VS 2027 (USD MILLION)
  • FIGURE 25. GLOBAL SPECIALTY GENERICS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USE, 2027
  • FIGURE 26. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2027 (USD MILLION)
  • FIGURE 27. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
  • FIGURE 28. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2027 (USD MILLION)
  • FIGURE 29. AMERICAS SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 30. AMERICAS SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 31. AMERICAS SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 32. AMERICAS SPECIALTY GENERICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
  • FIGURE 33. ARGENTINA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 34. BRAZIL SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 35. CANADA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 36. MEXICO SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 37. UNITED STATES SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 38. UNITED STATES SPECIALTY GENERICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
  • FIGURE 39. UNITED STATES SPECIALTY GENERICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
  • FIGURE 40. UNITED STATES SPECIALTY GENERICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
  • FIGURE 41. ASIA-PACIFIC SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 42. ASIA-PACIFIC SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 43. ASIA-PACIFIC SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 44. ASIA-PACIFIC SPECIALTY GENERICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
  • FIGURE 45. AUSTRALIA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 46. CHINA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 47. INDIA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 48. INDONESIA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 49. JAPAN SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 50. MALAYSIA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 51. PHILIPPINES SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 52. SINGAPORE SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 53. SOUTH KOREA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 54. TAIWAN SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 55. THAILAND SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 56. VIETNAM SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 57. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 58. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 59. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 60. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
  • FIGURE 61. DENMARK SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 62. EGYPT SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 63. FINLAND SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 64. FRANCE SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 65. GERMANY SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 66. ISRAEL SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 67. ITALY SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 68. NETHERLANDS SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 69. NIGERIA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 70. NORWAY SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 71. POLAND SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 72. QATAR SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 73. RUSSIA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 74. SAUDI ARABIA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 75. SOUTH AFRICA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 76. SPAIN SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 77. SWEDEN SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 78. SWITZERLAND SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 79. TURKEY SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 80. UNITED ARAB EMIRATES SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 81. UNITED KINGDOM SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 82. GLOBAL SPECIALTY GENERICS MARKET: FPNV POSITIONING MATRIX, 2021
  • FIGURE 83. GLOBAL SPECIALTY GENERICS MARKET SHARE, BY KEY PLAYER, 2021
  • FIGURE 84. GLOBAL SPECIALTY GENERICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021

LIST OF TABLES

  • TABLE 1. GLOBAL SPECIALTY GENERICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
  • TABLE 3. GLOBAL SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 4. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 5. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 6. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 7. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY INJECTABLES, 2018-2027 (USD MILLION)
  • TABLE 8. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 9. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY ORAL DRUGS, 2018-2027 (USD MILLION)
  • TABLE 11. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY ORAL DRUGS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 12. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY ORAL DRUGS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 14. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY HEPATITIS C, 2018-2027 (USD MILLION)
  • TABLE 15. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY HEPATITIS C, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 16. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY HEPATITIS C, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY INFLAMMATORY CONDITIONS, 2018-2027 (USD MILLION)
  • TABLE 18. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY INFLAMMATORY CONDITIONS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 19. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY INFLAMMATORY CONDITIONS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 20. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2027 (USD MILLION)
  • TABLE 21. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 22. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 23. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD MILLION)
  • TABLE 24. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 25. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 26. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 27. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2027 (USD MILLION)
  • TABLE 28. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 29. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 30. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
  • TABLE 31. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 32. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 33. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2027 (USD MILLION)
  • TABLE 34. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 35. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 36. AMERICAS SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 37. AMERICAS SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 38. AMERICAS SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 39. AMERICAS SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 40. AMERICAS SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 41. ARGENTINA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 42. ARGENTINA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 43. ARGENTINA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 44. ARGENTINA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 45. BRAZIL SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 46. BRAZIL SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 47. BRAZIL SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 48. BRAZIL SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 49. CANADA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 50. CANADA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 51. CANADA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 52. CANADA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 53. MEXICO SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 54. MEXICO SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 55. MEXICO SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 56. MEXICO SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 57. UNITED STATES SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 58. UNITED STATES SPECIALTY GENERICS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
  • TABLE 59. UNITED STATES SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 60. UNITED STATES SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 61. UNITED STATES SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 67. AUSTRALIA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 68. AUSTRALIA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 69. AUSTRALIA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 70. AUSTRALIA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 71. CHINA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 72. CHINA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 73. CHINA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 74. CHINA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 75. INDIA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 76. INDIA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 77. INDIA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 78. INDIA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 79. INDONESIA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 80. INDONESIA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 81. INDONESIA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 82. INDONESIA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 83. JAPAN SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 84. JAPAN SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 85. JAPAN SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 86. JAPAN SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 87. MALAYSIA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 88. MALAYSIA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 89. MALAYSIA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 90. MALAYSIA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 91. PHILIPPINES SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 92. PHILIPPINES SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 93. PHILIPPINES SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 94. PHILIPPINES SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 95. SINGAPORE SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 96. SINGAPORE SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 97. SINGAPORE SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 98. SINGAPORE SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 99. SOUTH KOREA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 100. SOUTH KOREA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 101. SOUTH KOREA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 102. SOUTH KOREA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 103. TAIWAN SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 104. TAIWAN SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 105. TAIWAN SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 106. TAIWAN SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 107. THAILAND SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 108. THAILAND SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 109. THAILAND SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 110. THAILAND SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 111. VIETNAM SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 112. VIETNAM SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 113. VIETNAM SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 114. VIETNAM SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 120. DENMARK SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 121. DENMARK SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 122. DENMARK SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 123. DENMARK SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 124. EGYPT SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 125. EGYPT SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 126. EGYPT SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 127. EGYPT SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 128. FINLAND SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 129. FINLAND SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 130. FINLAND SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 131. FINLAND SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 132. FRANCE SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 133. FRANCE SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 134. FRANCE SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 135. FRANCE SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 136. GERMANY SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 137. GERMANY SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 138. GERMANY SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 139. GERMANY SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 140. ISRAEL SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 141. ISRAEL SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 142. ISRAEL SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 143. ISRAEL SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 144. ITALY SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 145. ITALY SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 146. ITALY SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 147. ITALY SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 148. NETHERLANDS SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 149. NETHERLANDS SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 150. NETHERLANDS SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 151. NETHERLANDS SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 152. NIGERIA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 153. NIGERIA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 154. NIGERIA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 155. NIGERIA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 156. NORWAY SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 157. NORWAY SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 158. NORWAY SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 159. NORWAY SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 160. POLAND SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 161. POLAND SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 162. POLAND SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 163. POLAND SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 164. QATAR SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 165. QATAR SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 166. QATAR SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 167. QATAR SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 168. RUSSIA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 169. RUSSIA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 170. RUSSIA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 171. RUSSIA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 172. SAUDI ARABIA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 173. SAUDI ARABIA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 174. SAUDI ARABIA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 175. SAUDI ARABIA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 176. SOUTH AFRICA SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 177. SOUTH AFRICA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 178. SOUTH AFRICA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 179. SOUTH AFRICA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 180. SPAIN SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 181. SPAIN SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 182. SPAIN SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 183. SPAIN SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 184. SWEDEN SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 185. SWEDEN SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 186. SWEDEN SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 187. SWEDEN SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 188. SWITZERLAND SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 189. SWITZERLAND SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 190. SWITZERLAND SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 191. SWITZERLAND SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 192. TURKEY SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 193. TURKEY SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 194. TURKEY SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 195. TURKEY SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 196. UNITED ARAB EMIRATES SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 197. UNITED ARAB EMIRATES SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 198. UNITED ARAB EMIRATES SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 199. UNITED ARAB EMIRATES SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 200. UNITED KINGDOM SPECIALTY GENERICS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 201. UNITED KINGDOM SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 202. UNITED KINGDOM SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 203. UNITED KINGDOM SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
  • TABLE 204. GLOBAL SPECIALTY GENERICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
  • TABLE 205. GLOBAL SPECIALTY GENERICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
  • TABLE 206. GLOBAL SPECIALTY GENERICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
  • TABLE 207. GLOBAL SPECIALTY GENERICS MARKET RANKING, BY KEY PLAYER, 2021
  • TABLE 208. GLOBAL SPECIALTY GENERICS MARKET SHARE, BY KEY PLAYER, 2021
  • TABLE 209. GLOBAL SPECIALTY GENERICS MARKET MERGER & ACQUISITION
  • TABLE 210. GLOBAL SPECIALTY GENERICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 211. GLOBAL SPECIALTY GENERICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 212. GLOBAL SPECIALTY GENERICS MARKET INVESTMENT & FUNDING
  • TABLE 213. GLOBAL SPECIALTY GENERICS MARKET AWARD, RECOGNITION, & EXPANSION
  • TABLE 214. GLOBAL SPECIALTY GENERICS MARKET: LICENSE & PRICING
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!